110
Views
7
CrossRef citations to date
0
Altmetric
Research Article

Combination therapy Eve and Pac to induce apoptosis in cervical cancer cells by targeting PI3K/AKT/mTOR pathways

, , &
Pages 83-88 | Received 28 Nov 2017, Accepted 08 Jan 2018, Published online: 25 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (6)

Jiawei Li, Fangfang Li, Yuqing Zhao & Dan Jin. (2023) Integrating network pharmacology and experimental validation to explore the effect and mechanism of AD-1 in the treatment of colorectal cancer. Frontiers in Pharmacology 14.
Crossref
Chun Zhou, Fang Wu, Mengjie Liang, Jiayi Li & Yuping Shao. (2022) Anti-Programmed Death Protein-1 (PD-1) Antibody Combined with Paclitaxel Exert Anti-Cancer Effect on Cervical Cancer Cells. Journal of Biomaterials and Tissue Engineering 12:8, pages 1664-1669.
Crossref
Forough Alemi, Aydin Raei sadigh, Faezeh Malakoti, Yusuf Elhaei, Seyed Hamed Ghaffari, Masomeh Maleki, Zatollah Asemi, Bahman Yousefi, Niloufar Targhazeh & Maryam Majidinia. (2021) Molecular mechanisms involved in DNA repair in human cancers: An overview of PI3k/Akt signaling and PIKKs crosstalk. Journal of Cellular Physiology 237:1, pages 313-328.
Crossref
Zhenhong Fu, David Mui, Hang Zhu & Ying Zhang. (2020) Exenatide inhibits NF-κB and attenuates ER stress in diabetic cardiomyocyte models. Aging 12:9, pages 8640-8651.
Crossref
Xiao-Long Yuan, Xin-Xin Mao, Yong-Mei Du, Pei-Zhen Yan, Xiao-Dong Hou & Zhong-Feng Zhang. (2019) Anti-Tumor Activity of Cembranoid-Type Diterpenes Isolated from Nicotiana tabacum L.. Biomolecules 9:2, pages 45.
Crossref
Bisheng Zhu, Qisheng Liu, Qi Han, Bohang Zeng, Jingqi Chen & Qiuju Xiao. (2018) Downregulation of Kr�ppel‑like factor 1 inhibits the metastasis and invasion of cervical cancer cells. Molecular Medicine Reports.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.